Rafferty Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.47M Sell
10,452
-78
-0.7% -$37.3K 0.02% 335
2025
Q4
$6.13M Sell
10,530
-8,185
-44% -$4.18M 0.02% 370
2025
Q3
$8.58M Sell
18,715
-5,818
-24% -$2.17M 0.03% 309
2025
Q2
$7.42M Sell
24,533
-5,369
-18% -$1.6M 0.02% 327
2025
Q1
$9.9M Sell
29,902
-3,221
-10% -$1.06M 0.04% 263
2024
Q4
$10.2M Sell
33,123
-11,501
-26% -$3.23M 0.04% 280
2024
Q3
$9.47M Buy
44,624
+8,206
+23% +$2.1M 0.03% 291
2024
Q2
$10.2M Buy
36,418
+501
+1% +$119K 0.04% 280
2024
Q1
$9.59M Sell
35,917
-7,182
-17% -$1.69M 0.04% 276
2023
Q4
$9.97M Sell
43,099
-2,224
-5% -$389K 0.04% 279
2023
Q3
$6.62M Buy
45,323
+14,067
+45% +$2.65M 0.04% 333
2023
Q2
$7.22M Buy
31,256
+3,121
+11% +$845K 0.04% 329
2023
Q1
$6.82M Sell
28,135
-77,255
-73% -$21.1M 0.05% 301
2022
Q4
$30.6M Buy
105,390
+39,469
+60% +$3.86M 0.26% 66
2022
Q3
$4.28M Buy
65,921
+34,761
+112% +$2.42M 0.05% 362
2022
Q2
$2.23M Sell
31,160
-15,127
-33% -$1.11M 0.02% 439
2022
Q1
$4.54M Buy
46,287
+9,740
+27% +$821K 0.03% 411
2021
Q4
$3.1M Buy
36,547
+5,091
+16% +$418K 0.02% 528
2021
Q3
$2.51M Buy
31,456
+7,291
+30% +$630K 0.02% 563
2021
Q2
$2.35M Sell
24,165
-4,110
-15% -$487K 0.01% 640
2021
Q1
$3.31M Buy
28,275
+21,301
+305% +$2.48M 0.02% 425
2020
Q4
$775K Sell
6,974
-3,532
-34% -$432K 0.01% 580
2020
Q3
$1.25M Buy
10,506
+2,903
+38% +$315K 0.02% 544
2020
Q2
$861K Buy
+7,603
New +$748K 0.01% 586
2020
Q1
Sell
-15,679
Closed -$1.43M 728
2019
Q4
$1.43M Sell
15,679
-18,551
-54% -$1.8M 0.02% 468
2019
Q3
$2.95M Sell
34,230
-4,989
-13% -$468K 0.05% 233
2019
Q2
$4.11M Buy
39,219
+7,708
+24% +$826K 0.07% 204
2019
Q1
$3.95M Buy
+31,511
New +$3.92M 0.06% 172

Other funds holding MDGL